Company Overview
InpharmD is an Atlanta, Georgia-based healthcare technology company founded in 2018 that provides clinical pharmacist-reviewed, AI-generated drug information and pharmaceutical intelligence for healthcare providers. The YC W21 company raised $6.63M total funding including a $6.5M seed round in December 2023 led by 645 Ventures with participation from Y Combinator, Qlarant Capital, ELC, Atlanta Ventures and others, and successfully deployed Avesha's Elastic GPU Service to Nebius AI Cloud in July 2025.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
InpharmD is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
AI Visibility Rankings
How InpharmD performs in AI search results
Unlock AI Visibility Tracking for InpharmD
See exactly how InpharmD ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.
Join 1,000+ brands · Free 7-day trial · No credit card required
Not So Random Others
In-N-Out Burger
In-N-Out Burger is a regional fast-food chain known for its simple menu of fresh, made-to-order burgers, fries, and shakes with a cult following in the Western United States. The company serves custom
Assurtiv
Assurtiv Technologies Private Limited represents the newest generation of GRC (Governance, Risk, and Compliance) platform innovation, incorporated in October 2024 in Hyderabad, India. As a recently la
Bynder
Bynder is a digital asset management (DAM) platform helping marketing and creative teams organize, manage, and distribute brand assets and content. The company provides centralized storage, version co
Bamboo
Bamboo is Africa's leading online brokerage platform enabling Africans to invest in US stocks, ETFs, and Nigerian stocks through fractional investing, making global investing accessible from as little
Airmeet
Airmeet is a virtual and hybrid event platform that enables organizations to host interactive conferences, meetups, webinars, and workshops with networking and engagement features. The platform serves
Crustdata
$6M Seed (YC/A Capital); Garry Tan doubling down; $4M+ revenue; YC/agent.ai/MNTN clients; YC F24
Compare with Other Brands
See how InpharmD stacks up against competitors with our detailed comparison tool.
Start Comparison